COVID-19, an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread throughout the world. China has achieved rapid containment of this highly infectious disease following the principles of early detection, early quarantine and early treatment with integrated traditional Chinese and Western medicine. The inclusion of traditional Chinese medicine (TCM) in the Chinese protocol is based on its successful historic experience in fighting against pestilence. Current findings have shown that the Chinese medicine can reduce the incidence of severe or critical events, improve clinical recovery and help alleviate symptoms such as cough or fever.
To date there are over 133 ongoing registered clinical studies on TCM/integrated traditional Chinese and Western medicine. The three Chinese patent medicines (Lianhua Qingwen Keli/Jiaonang (Forsythiae and Honeysuckle Flower Pestilence-Clearing Granules/Capsules), Jinhua Qinggan Keli (Honeysuckle Flower Cold-Relieving Granules) and Xuebijing (Stasis-Resolving & Toxin-Removing) Injection were officially approved by the National Medical Products Administration to list COVID-19 as an additional indication. The pharmacological studies have suggested that Chinese medicine is effective for COVID-19 probably through its host-directed regulation and certain antiviral effects.
Randomisierte kontrollierte Studie zur Zervikalreifung und Weheninduktion mithilfe der Akupunktur
Rabl M, Ahner R, Bitschnau M, Zeisler H, Husslein …; 2001
Prospektive randomisierte Studie zum Wirkvergleich Qigong und inviduelle Bewegungstherapie bei langfristigen Nackenschmerzen
Lansinger B, Larsson E, Persson LC, Carlsson JY; 2007
Randomisierte kontrollierte klinische Studie zur Wirksamkeit der Bauchakupunktur bei Frauen mit Schlaflosigkeit
Wang XY, Yuan SH, Yang HY, Sun YM, Cheng FP, Zhang…; 2008